ATE165356T1 - Verfahren zur herstellung von benzoesäurederivaten als zwischenprodukte und benzothiophenen als pharmazeutische mittel - Google Patents

Verfahren zur herstellung von benzoesäurederivaten als zwischenprodukte und benzothiophenen als pharmazeutische mittel

Info

Publication number
ATE165356T1
ATE165356T1 AT95306053T AT95306053T ATE165356T1 AT E165356 T1 ATE165356 T1 AT E165356T1 AT 95306053 T AT95306053 T AT 95306053T AT 95306053 T AT95306053 T AT 95306053T AT E165356 T1 ATE165356 T1 AT E165356T1
Authority
AT
Austria
Prior art keywords
compound
formula
product
chem
alkyl
Prior art date
Application number
AT95306053T
Other languages
English (en)
Inventor
Douglas Patton Kjell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE165356T1 publication Critical patent/ATE165356T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT95306053T 1994-08-31 1995-08-30 Verfahren zur herstellung von benzoesäurederivaten als zwischenprodukte und benzothiophenen als pharmazeutische mittel ATE165356T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,891 US5731436A (en) 1994-08-31 1994-08-31 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Publications (1)

Publication Number Publication Date
ATE165356T1 true ATE165356T1 (de) 1998-05-15

Family

ID=23152424

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95306053T ATE165356T1 (de) 1994-08-31 1995-08-30 Verfahren zur herstellung von benzoesäurederivaten als zwischenprodukte und benzothiophenen als pharmazeutische mittel

Country Status (15)

Country Link
US (2) US5731436A (de)
EP (1) EP0699673B1 (de)
JP (1) JPH08119912A (de)
KR (1) KR960007544A (de)
AT (1) ATE165356T1 (de)
BR (1) BR9503847A (de)
CA (1) CA2157235A1 (de)
DE (1) DE69502153T2 (de)
DK (1) DK0699673T3 (de)
ES (1) ES2114722T3 (de)
FI (1) FI954068A7 (de)
GR (1) GR3026743T3 (de)
HU (1) HUT73136A (de)
IL (3) IL126593A (de)
TW (1) TW368497B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
CA2213810C (en) * 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
US5948796A (en) * 1996-10-10 1999-09-07 Eli Lilly And Company Benzo B!thiophene compounds, intermediates, formulations, and methods
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US6017914A (en) * 1997-09-03 2000-01-25 Eli Lilly And Company Benzo[b]thiophene compounds, intermediates, formulations, and methods
FR2817865B1 (fr) * 2000-12-11 2005-02-18 Sanofi Synthelabo Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
AU2003266940B2 (en) 2002-09-30 2007-02-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
JP5603019B2 (ja) * 2008-03-26 2014-10-08 帝人株式会社 植物由来成分を有するポリエステルおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864501A (en) * 1973-10-10 1975-02-04 Us Agriculture Method of enhancing coloration of fruits and vegetables with a dialhylamino-alkoxybenzene
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
WO1989003819A1 (fr) * 1987-10-20 1989-05-05 Otsuka Pharmaceutical Co., Ltd. Derives d'acide phenylcarboxylique
JPH02101048A (ja) * 1988-10-07 1990-04-12 Fuji Photo Film Co Ltd サリチル酸誘導体の製造方法
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
IL115091A0 (en) 1995-12-08
BR9503847A (pt) 1996-09-17
EP0699673B1 (de) 1998-04-22
KR960007544A (ko) 1996-03-22
EP0699673A1 (de) 1996-03-06
FI954068A7 (fi) 1996-03-01
DE69502153D1 (de) 1998-05-28
IL126593A (en) 2000-08-31
US5731436A (en) 1998-03-24
JPH08119912A (ja) 1996-05-14
IL126593A0 (en) 1999-08-17
HUT73136A (en) 1996-06-28
HU9502539D0 (en) 1995-10-30
DK0699673T3 (da) 1998-10-07
DE69502153T2 (de) 1998-09-17
IL115091A (en) 2000-08-31
CA2157235A1 (en) 1996-03-01
US5955608A (en) 1999-09-21
FI954068A0 (fi) 1995-08-30
TW368497B (en) 1999-09-01
GR3026743T3 (en) 1998-07-31
ES2114722T3 (es) 1998-06-01

Similar Documents

Publication Publication Date Title
ATE165356T1 (de) Verfahren zur herstellung von benzoesäurederivaten als zwischenprodukte und benzothiophenen als pharmazeutische mittel
US3822287A (en) Process for preparation of substituted 3,4-(diphenyl)chromans
DE69502152D1 (de) Verfahren zur Herstellung von Benzoesäurederivaten als Zwischenprodukte und Benzothiophenen als pharmazeutische Mittel
NO893777D0 (no) 7-substituerte derivater av 3,5-dihydroksihept-6-insyre, fremgangsmaate til deres fremstilling, deres anvendelse somlegemiddel, saavel som mellomprodukter.
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR860003221A (ko) 1-[(아미노알킬 및 아미노알킬아미노)카보닐 및 티오카보닐]-α, α-디아릴피롤리딘, 피페리딘 및 호모피페리딘 아세트아미드 및 아세토니트릴의 제조방법
US5102882A (en) Pyroglutamide derivatives
ATE143020T1 (de) Aminocarbonylcarbamate verwandt mit physostigmin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE201024T1 (de) Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE273263T1 (de) Verfahren zur kontinuierlichen herstellung von glutaraldehyd
HU219493B (hu) Alkil-trazodon-származékok előállítására alkalmazható piperazinszármazékok és eljárás előállításukra
DE68906519D1 (de) Aryloxypropanolaminotetraline, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel.
CA2127292A1 (en) Process for producing hydroxyalkane carboxylic acid amides
ATE336482T1 (de) Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung
WO1997034884A1 (en) Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
US3095425A (en) Alkanoylthiaxanthenes and-xanthenes
US2980672A (en) Phenothiazine tfflocarboxyiates
ATE110376T1 (de) Biphenyl-derivate, verfahren zu deren herstellung und deren zwischenprodukte.
FI86181C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (1,2,3,4,4a,10a-hexahydrodibenso/b,e//1,4/-dioxin -4-yloxi) etylammoniumderivat.
WO1997038990A1 (en) Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
HU189227B (en) Process for preparing basic oxime-ethers
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee